The company is paying China-based biotech LaNova Medicines $588 million for the kind of dual-pronged antibody drug that ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

Merck's undervalued stock presents growth opportunities with Keytruda and promising pipeline drugs, making it a Buy despite ...

Virtual screening is a computational approach used to identify chemical structures that are predicted to have particular properties. For example, in the context of drug discovery, it may involve ...

If so, you’ve likely discovered job postings advertising virtual assistant (VA) roles. Now you’re intrigued, and rightly so. Virtual assistant jobs have much to offer, and you should take a closer ...

Commissions do not affect our editors' opinions or evaluations. A virtual terminal allows businesses to key in a customer’s credit card information to process a transaction, even if the customer ...

Whether you shoot portraits, products or still-life images, a good clean backdrop will enable you to quickly create a clean or artistic background against which to shoot your subject. Many ...

Merck & Co., Inc.'s Q3 earnings report is anticipated on 31st October — next Thursday. Despite strong Q2 performance, Merck's stock fell due to a guidance downgrade related to issues with key ...

Despite Merck & Co. homing in on approval for its infant respiratory syncytial virus (RSV) antibody clesrovimab, Sanofi—which last year won its own nod for its AstraZeneca-partnered RSV ...

Merck’s acquisition of Modifi Biosciences will give it access to preclinical cancer drug candidates that target DNA repair processes. Modifi Biosciences, a spin out of Yale University founded in 2021, ...

Oct. 23, 2024 (GLOBE NEWSWIRE) -- Modifi Biosciences, Inc. (“Modifi Biosciences”), a leader in the development of direct DNA modification enabled cancer therapeutics, today announced that the company ...